GT BIOPHARMA, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2009 | — | — | $1.3M |
| FY2010 | — | $-5.5M | $54.0K |
| FY2011 | — | $-5.1M | $92.0K |
| FY2012 | — | $-6.3M | $61.0K |
| FY2013 | — | $-6.3M | $43.0K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2009 | — | — | $1.3M |
| FY2010 | — | $-5.5M | $54.0K |
| FY2011 | — | $-5.1M | $92.0K |
| FY2012 | — | $-6.3M | $61.0K |
| FY2013 | — | $-6.3M | $43.0K |